Sanofi CEO: UK is 'terrible place' for medicines
Sanofi executive warns of UK's worsening medicines access crisis, citing post-Brexit regulations, NICE hurdles, and a pricing system that deters investment and innovation.
Category : Search result: Sanofi
NHS approves revolutionary diabetes treatment
The NHS has finally approved a groundbreaking artificial pancreas system for Type 1 diabetes patients following years of campaigning by families and charities.
Page 1 of 1